Appearing as a noteworthy advance in the battle against obesity, this medication is attracting considerable buzz. It combines effects of two recognized GLP-1 receptor agonists, dulaglutide , with an additional glucose-dependent hormonal component. Early clinical data have demonstrated impressive weight loss in patients with a high BMI , perhaps pr